Research Overview

Dr. Greene’s research is focused on three main areas:

Vascular anomalies 
Vascular anomalies are a group of tumors and malformations that affect blood vessels. We are studying resected human lesions to determine their causative somatic mutation and the mechanisms responsible for their progression. Our goal is to develop novel pharmacological treatments for patients with vascular anomalies.

Lymphedema
Lymphedema is a disease that causes extremity swelling. We have shown that extreme obesity can cause this condition, which we named “obesity-induced lymphedema”. We are studying the relationship between obesity and lymphedema.

Cranioplasty

Cranioplasty in young children is difficult because of limited autologous donor sites and the reluctance to use alloplastic materials. We have popularized and studied a cranioplasty technique we termed “particulate bone grafting”. We have translated our technique to an animal model and are comparing particulate graft to other cranioplasty materials.

Research Background

Dr. Greene received his MD from the University of Illinois School of Medicine, and his MMSc in vascular anomalies from Harvard Medical School. He completed an internship and residency in general surgery at Beth Israel Deaconess Medical Center, followed by a plastic surgery residency with the Harvard Plastic Surgery Training Program. Dr. Greene has completed two fellowships at Boston Children’s Hospital, including a research fellowship in the Department of Surgery and a fellowship in Craniofacial & Pediatric Plastic Surgery.

 

Education

Undergraduate School

University of Chicago
1993 Chicago IL

Graduate School

Translational Research, MMsC Harvard Medical School
2003 Boston MA

Medical School

University of Illinois College of Medicine
1997 Chicago IL

Residency

General Surgery Beth Israel Deaconess Medical Center
2000 Boston MA

Residency

Plastic Surgery Beth Israel Deaconess Medical Center
2005 Boston MA

Residency

Chief Resident; Plastic Surgery Beth Israel Deaconess Medical Center
2006 Boston MA

Fellowship

Angiogenesis Research Boston Children's Hospital/Harvard Medical School
2003 Boston MA

Fellowship

Craniofacial/Pediatric Plastic Surgery Boston Children's Hospital
2007 Boston MA

Publications

  1. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. J Clin Invest. 2024 May 30; 134(14). View Abstract
  2. The Lymphedematous Limb as a Donor Site for Breast Fat Grafting. Plast Reconstr Surg Glob Open. 2024 May; 12(5):e5824. View Abstract
  3. Understanding Hematoma Risk: Study of Patient and Perioperative Factors in a Large Cohort of Young Women Undergoing Reduction Mammaplasty. J Am Coll Surg. 2024 May 01; 238(5):900-910. View Abstract
  4. MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome. Acta Neuropathol Commun. 2024 Mar 26; 12(1):47. View Abstract
  5. PPAR? agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRa+ mesenchymal cells. JCI Insight. 2023 12 22; 8(24). View Abstract
  6. Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations. Am J Surg Pathol. 2024 Jan 01; 48(1):106-111. View Abstract
  7. Game Changers: Plastic and Reconstructive Surgery Innovations of the Last 100 Years. Plast Reconstr Surg Glob Open. 2023 Aug; 11(8):e5209. View Abstract
  8. Arteriovenous malformation Map2k1 mutation affects vasculogenesis. Sci Rep. 2023 07 08; 13(1):11074. View Abstract
  9. Power-assisted Liposuction for Lymphedema: A Cost-utility Analysis. Plast Reconstr Surg Glob Open. 2022 Nov; 10(11):e4671. View Abstract
  10. Endothelial cell expression of mutant Map2k1 causes vascular malformations in mice. Angiogenesis. 2023 02; 26(1):97-105. View Abstract
  11. How we approach lymphedema in the pediatric population. Pediatr Blood Cancer. 2022 08; 69 Suppl 3:e29908. View Abstract
  12. Lymphedema and Obesity. Cold Spring Harb Perspect Med. 2022 05 27; 12(5). View Abstract
  13. How we approach lymphedema in the pediatric population. Pediatr Blood Cancer. 2022 08; 69(8):e29611. View Abstract
  14. Parkes Weber syndrome with lymphedema caused by a somatic KRAS variant. Cold Spring Harb Mol Case Stud. 2021 12; 7(6). View Abstract
  15. Bockenheimer disease is associated with a TEK variant. Cold Spring Harb Mol Case Stud. 2021 12; 7(6). View Abstract
  16. Realizing topologically ordered states on a quantum processor. Science. 2021 Dec 03; 374(6572):1237-1241. View Abstract
  17. Verrucous Venous Malformation-Subcutaneous Variant. Am J Dermatopathol. 2021 Dec 01; 43(12):e181-e184. View Abstract
  18. Lymphedema and Sports: A Case Series of Athletic Patients. Lymphat Res Biol. 2022 10; 20(5):522-524. View Abstract
  19. Endothelial GNAQ p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels. Arterioscler Thromb Vasc Biol. 2022 01; 42(1):e27-e43. View Abstract
  20. EPHB4 mutation causes adult and adolescent-onset primary lymphedema. Am J Med Genet A. 2021 12; 185(12):3810-3813. View Abstract
  21. Discussion: Surgical Treatment of Peripheral Vascular Malformations: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2021 05 01; 147(5):1162-1163. View Abstract
  22. Vascular Malformations: Current Progress Toward Drug Therapy. J Craniofac Surg. 2021 May 01; 32(Suppl 3):1211-1215. View Abstract
  23. A Biphasic Osteovascular Biomimetic Scaffold for Rapid and Self-Sustained Endochondral Ossification. Adv Healthc Mater. 2021 07; 10(13):e2100070. View Abstract
  24. Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference. Plast Reconstr Surg. 2021 04 01; 147(4):975-993. View Abstract
  25. Lower Extremity Reconstruction in the Pediatric Population. Clin Plast Surg. 2021 Apr; 48(2):341-347. View Abstract
  26. Primary Lymphedema: Update on Genetic Basis and Management. Adv Wound Care (New Rochelle). 2022 07; 11(7):374-381. View Abstract
  27. Current Overview of Obesity-Induced Lymphedema. Adv Wound Care (New Rochelle). 2022 07; 11(7):392-398. View Abstract
  28. Human endothelial colony-forming cells provide trophic support for pluripotent stem cell-derived cardiomyocytes via distinctively high expression of neuregulin-1. Angiogenesis. 2021 05; 24(2):327-344. View Abstract
  29. Lower Extremity Lymphatic Function in Nonambulatory Patients with Neuromuscular Disease. Lymphat Res Biol. 2021 04; 19(2):126-128. View Abstract
  30. Lipoblastoma phenotype contains a somatic PIK3CA mutation. Pediatr Dermatol. 2021 Jan; 38(1):299-300. View Abstract
  31. Lymphedema (Seminars in pediatric surgery). Semin Pediatr Surg. 2020 Oct; 29(5):150972. View Abstract
  32. Lower extremity lymphatic function predicted by body mass index: a lymphoscintigraphic study of obesity and lipedema. Int J Obes (Lond). 2021 02; 45(2):369-373. View Abstract
  33. Arteriovenous malformation phenotype resembling congenital hemangioma contains KRAS mutations. Clin Genet. 2020 12; 98(6):595-597. View Abstract
  34. Body Mass Index and Lymphedema Morbidity: Comparison of Obese versus Normal-Weight Patients. Plast Reconstr Surg. 2020 08; 146(2):402-407. View Abstract
  35. Congenital Disseminated Pyogenic Granuloma: Characterization of an Aggressive Multisystemic Disorder. J Pediatr. 2020 11; 226:157-166. View Abstract
  36. Endothelial MAP2K1 mutations in arteriovenous malformation activate the RAS/MAPK pathway. Biochem Biophys Res Commun. 2020 08 20; 529(2):450-454. View Abstract
  37. Elevation of Costal Cartilage Ear Construct for Microtia Using a V-Y Scalp Flap. J Craniofac Surg. 2020 Jul-Aug; 31(5):1467-1468. View Abstract
  38. Study of 700 Referrals to a Lymphedema Program. Lymphat Res Biol. 2020 12; 18(6):534-538. View Abstract
  39. Body Mass Index and Lymphedema Morbidity: Comparison of Obese Versus Normal-Weighted Patients. Plast Reconstr Surg. 2020 Apr 27. View Abstract
  40. Arteriovenous Malformation MAP2K1 Mutation Causes Local Cartilage Overgrowth by a Cell-Non Autonomous Mechanism. Sci Rep. 2020 03 10; 10(1):4428. View Abstract
  41. Surgical Management of Fibroadipose Vascular Anomaly of the Lower Extremities. J Pediatr Orthop. 2020 Mar; 40(3):e227-e236. View Abstract
  42. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants. Clin Genet. 2020 05; 97(5):736-740. View Abstract
  43. Somatic mutations in intracranial arteriovenous malformations. PLoS One. 2019; 14(12):e0226852. View Abstract
  44. Arteriovenous malformation associated with a HRAS mutation. Hum Genet. 2019 Dec; 138(11-12):1419-1421. View Abstract
  45. Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. Angiogenesis. 2019 11; 22(4):547-552. View Abstract
  46. Fibroadipose Vascular Anomaly in the Upper Extremity: A Distinct Entity With Characteristic Clinical, Radiological, and Histopathological Findings. J Hand Surg Am. 2020 Jan; 45(1):68.e1-68.e13. View Abstract
  47. Sensitivity and Specificity of the Stemmer Sign for Lymphedema: A Clinical Lymphoscintigraphic Study. Plast Reconstr Surg Glob Open. 2019 Jun; 7(6):e2295. View Abstract
  48. Lymphoscintigraphic Evaluation of Systemic Tracer Uptake in Patients With Primary Lymphedema. Ann Plast Surg. 2019 04; 82(4S Suppl 3):S212-S214. View Abstract
  49. Adult-Onset Primary Lymphedema: A Clinical-Lymphoscintigraphic Study of 26 Patients. Lymphat Res Biol. 2019 12; 17(6):620-623. View Abstract
  50. Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma. JAMA Ophthalmol. 2019 01 01; 137(1):91-95. View Abstract
  51. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics. 2019 01; 143(1). View Abstract
  52. Primary Lymphedema of the Upper Extremities: Clinical and Lymphoscintigraphic Features in 23 Patients. Lymphat Res Biol. 2019 Feb; 17(1):40-44. View Abstract
  53. Vascular Malformation Enlargement During Menopause. J Craniofac Surg. 2018 Jul; 29(5):1271-1272. View Abstract
  54. Vascular Anomalies: From a Clinicohistologic to a Genetic Framework. Plast Reconstr Surg. 2018 05; 141(5):709e-717e. View Abstract
  55. Diagnosis and Staging of Lymphedema. Semin Plast Surg. 2018 Feb; 32(1):12-16. View Abstract
  56. Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma. Ann Plast Surg. 2018 04; 80(4 Suppl 4):S211-S213. View Abstract
  57. Congenital Vascular Tumors. Otolaryngol Clin North Am. 2018 Feb; 51(1):89-97. View Abstract
  58. Association between extremity kaposiform hemangioendothelioma and lymphedema. Pediatr Dermatol. 2018 Jan; 35(1):e92-e93. View Abstract
  59. Liposuction for Swelling in Patients with Lymphedema. N Engl J Med. 2017 11 02; 377(18):1788-1789. View Abstract
  60. Pediatric Orbital Floor Fractures: Clinical and Radiological Predictors of Tissue Entrapment and the Effect of Operative Timing on Ocular Outcomes. J Craniofac Surg. 2017 Nov; 28(8):1966-1971. View Abstract
  61. Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma. J Craniofac Surg. 2017 Nov; 28(8):2001-2003. View Abstract
  62. Role of imaging in the diagnosis of parotid infantile hemangiomas. Int J Pediatr Otorhinolaryngol. 2017 Nov; 102:61-66. View Abstract
  63. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis. Pediatr Res. 2017 Nov; 82(5):850-854. View Abstract
  64. Diagnostic Accuracy of Lymphoscintigraphy for Lymphedema and Analysis of False-Negative Tests. Plast Reconstr Surg Glob Open. 2017 Jul; 5(7):e1396. View Abstract
  65. Correlation Between Lymphedema Disease Severity and Lymphoscintigraphic Findings: A Clinical-Radiologic Study. J Am Coll Surg. 2017 Sep; 225(3):366-370. View Abstract
  66. Sonographic screening for Wilms tumor in children with CLOVES syndrome. Pediatr Blood Cancer. 2017 Dec; 64(12). View Abstract
  67. A Nonsurgical Approach to Adolescent Breast Asymmetry Using External Prostheses. J Adolesc Health. 2017 Aug; 61(2):240-245. View Abstract
  68. Resolution of Primary Lymphedema: A Case Report. Plast Reconstr Surg Glob Open. 2017 Feb; 5(2):e1223. View Abstract
  69. Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation. Am J Hum Genet. 2017 Mar 02; 100(3):546-554. View Abstract
  70. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Angiogenesis. 2017 Aug; 20(3):303-306. View Abstract
  71. Massive Localized Lymphedema: A Case-Control Study. J Am Coll Surg. 2017 Feb; 224(2):212-216. View Abstract
  72. Beckwith-Wiedemann Syndrome and Primary Lymphedema of the Lower Extremity. Pediatr Dermatol. 2017 Jan; 34(1):e51-e53. View Abstract
  73. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome. Pediatr Neurol. 2017 02; 67:59-63. View Abstract
  74. Operative Treatment of Lymphedema Using Suction-Assisted Lipectomy. Ann Plast Surg. 2016 Sep; 77(3):337-40. View Abstract
  75. Diagnosis and Management of Obesity-Induced Lymphedema. Plast Reconstr Surg. 2016 Jul; 138(1):111e-118e. View Abstract
  76. Bevacizumab and interferon reduce venous recanalization following sclerotherapy. J Pediatr Surg. 2016 Oct; 51(10):1670-3. View Abstract
  77. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. Am J Hum Genet. 2016 06 02; 98(6):1271. View Abstract
  78. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. Am J Hum Genet. 2016 Apr 07; 98(4):789-95. View Abstract
  79. Imaging features of kaposiform lymphangiomatosis. Pediatr Radiol. 2016 Aug; 46(9):1282-90. View Abstract
  80. Discussion: Surgical Treatment of Facial Infantile Hemangiomas: An Analysis Based on Tumor Characteristics and Outcomes. Plast Reconstr Surg. 2016 Apr; 137(4):1232-1233. View Abstract
  81. An Experimental Study of Particulate Bone Graft for Secondary Inlay Cranioplasty Over Scarred Dura. Ann Plast Surg. 2016 Apr; 76(4):438-41. View Abstract
  82. Reply: Obesity-Induced Lymphedema: Clinical and Lymphoscintigraphic Features. Plast Reconstr Surg. 2016 Mar; 137(3):648e. View Abstract
  83. Combined Lymphedema and Capillary Malformation of the Lower Extremity. Plast Reconstr Surg Glob Open. 2016 Feb; 4(2):e618. View Abstract
  84. Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations. Plast Reconstr Surg. 2016 Jan; 137(1):77e-82e. View Abstract
  85. Management of Vascular Anomalies and Related Conditions Using Suction-Assisted Tissue Removal. Plast Reconstr Surg. 2015 Oct; 136(4):511e-514e. View Abstract
  86. Facial Infiltrating Lipomatosis Contains Somatic PIK3CA Mutations in Multiple Tissues. Plast Reconstr Surg. 2015 Oct; 136(4 Suppl):72-3. View Abstract
  87. Management of Vascular Anomalies and Related Conditions Using Liposuction. Plast Reconstr Surg. 2015 Oct; 136(4 Suppl):154-5. View Abstract
  88. Diagnosis and Management of Infantile Hemangioma: Executive Summary. Pediatrics. 2015 Oct; 136(4):786-91. View Abstract
  89. Diagnosis and Management of Infantile Hemangioma. Pediatrics. 2015 Oct; 136(4):e1060-104. View Abstract
  90. Congenital Melanocytic Nevus of the Nose Removed Using Dermabrasion, Hydroquinone, and Serial Excision. J Craniofac Surg. 2015 Oct; 26(7):2216-7. View Abstract
  91. Weight Changes After Reduction Mammaplasty in Adolescents. J Adolesc Health. 2015 Sep; 57(3):277-81. View Abstract
  92. Nodular Foot Myxedema Masquerading as Lymphedema. Plast Reconstr Surg Glob Open. 2015 Jul; 3(7):e457. View Abstract
  93. Management of Primary and Secondary Lymphedema: Analysis of 225 Referrals to a Center. Ann Plast Surg. 2015 Aug; 75(2):197-200. View Abstract
  94. Obesity-induced Lymphedema Nonreversible following Massive Weight Loss. Plast Reconstr Surg Glob Open. 2015 Jun; 3(6):e426. View Abstract
  95. Reply: Psychological Impact of Breast Asymmetry on Adolescents: A Prospective Cohort. Plast Reconstr Surg. 2015 Jul; 136(1):109e-110e. View Abstract
  96. Circular Excision and Purse-String Closure for Pediatric Facial Skin Lesions. J Craniofac Surg. 2015 Jul; 26(5):1611-2. View Abstract
  97. Subcostal Skin Graft Donor Site for Autologous Ear Construction. J Craniofac Surg. 2015 Jun; 26(4):1372-3. View Abstract
  98. Obesity-induced lymphedema: clinical and lymphoscintigraphic features. Plast Reconstr Surg. 2015 Jun; 135(6):1715-1719. View Abstract
  99. A somatic MAP3K3 mutation is associated with verrucous venous malformation. Am J Hum Genet. 2015 Mar 05; 96(3):480-6. View Abstract
  100. Surgical Site Infection After Skin Excisions in Children: Is Field Sterility Sufficient? Pediatr Dermatol. 2016 Mar-Apr; 33(2):136-41. View Abstract
  101. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015 Apr; 166(4):1048-54.e1-5. View Abstract
  102. Stewart-Treves Phenomenon: Lymphangiosarcoma Arising in Lymphedematous Tissue Is not a Syndrome. Lymphat Res Biol. 2015 Sep; 13(3):228-9. View Abstract
  103. Facial wound closure in children using a 7-0 absorbable suture dressing. J Craniofac Surg. 2015 Jan; 26(1):76-8. View Abstract
  104. Management of challenging congenital melanocytic nevi: outcomes study of serial excision. J Pediatr Surg. 2015 Apr; 50(4):613-6. View Abstract
  105. Psychological impact of breast asymmetry on adolescents: a prospective cohort study. Plast Reconstr Surg. 2014 Dec; 134(6):1116-1123. View Abstract
  106. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis. 2015 Apr; 18(2):151-62. View Abstract
  107. Progressive Postnatal Pansynostosis. Cleft Palate Craniofac J. 2015 11; 52(6):751-7. View Abstract
  108. Repair of tegmen defect using cranial particulate bone graft. Am J Otolaryngol. 2015 Mar-Apr; 36(2):292-5. View Abstract
  109. An Experimental Study of Particulate Bone Graft for Secondary Inlay Cranioplasty over Scarred Dura. Plast Reconstr Surg. 2014 Oct; 134(4 Suppl 1):18. View Abstract
  110. Management of lymphedema with suction-assisted lipectomy. Plast Reconstr Surg. 2014 Oct; 134(4 Suppl 1):36. View Abstract
  111. Obesity-induced lymphedema: presentation, diagnosis, and management. Plast Reconstr Surg. 2014 Oct; 134(4 Suppl 1):108. View Abstract
  112. Infantile hemangioma: treatment rate during the proliferating phase. J Craniofac Surg. 2014 Sep; 25(5):1933-4. View Abstract
  113. Lymphedema. Semin Pediatr Surg. 2014 Aug; 23(4):191-7. View Abstract
  114. Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants. J Plast Reconstr Aesthet Surg. 2014 Nov; 67(11):1469-74. View Abstract
  115. Male genital lymphedema: clinical features and management in 25 pediatric patients. J Pediatr Surg. 2014 Nov; 49(11):1647-51. View Abstract
  116. Lymphedema and obesity: is there a link? Plast Reconstr Surg. 2014 Jul; 134(1):154e-160e. View Abstract
  117. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Proc Natl Acad Sci U S A. 2014 Jul 15; 111(28):10137-42. View Abstract
  118. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol. 2014 Dec; 37(6):1476-81. View Abstract
  119. Abstract 63: expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014 Apr; 133(4 Suppl):1024. View Abstract
  120. Expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014 Mar; 133(3):344e-351e. View Abstract
  121. Abstract 55: management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 87 consecutive infants. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):66. View Abstract
  122. Abstract 71: obesity-induced lymphedema: presentation, diagnosis, and management. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):82-83. View Abstract
  123. Abstract 75: expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):86. View Abstract
  124. Abstract 78: An Experimental Study of Particulate Bone Graft for Secondary Inlay Cranioplasty over Scarred Dura. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):90. View Abstract
  125. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop. 2014 Jan; 34(1):109-17. View Abstract
  126. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg. 2014 Jan; 133(1):12e-19e. View Abstract
  127. Obesity-induced Upper Extremity Lymphedema. Plast Reconstr Surg Glob Open. 2013 Oct; 1(7):e59. View Abstract
  128. Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential. Angiogenesis. 2013 Oct; 16(4):735-44. View Abstract
  129. Psychosocial impact of adolescent gynecomastia: a prospective case-control study. Plast Reconstr Surg. 2013 Apr; 131(4):890-896. View Abstract
  130. Extremity fasciotomy wound closure: comparison of skin grafting to staged linear closure. J Plast Reconstr Aesthet Surg. 2013 Mar; 66(3):e90-1. View Abstract
  131. Effect of calvarial burring on resorption of onlay cranial bone graft. J Craniofac Surg. 2012 Sep; 23(5):1495-8. View Abstract
  132. Reharvested cranial particulate bone graft ossifies inlay calvarial defects. J Craniofac Surg. 2012 Sep; 23(5):1499-501. View Abstract
  133. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg. 2012 Sep; 130(3):619-624. View Abstract
  134. Experimental Comparison of Cranial Particulate Bone Graft, rhBMP-2, and Split Cranial Bone Graft for Inlay Cranioplasty. Cleft Palate Craniofac J. 2013 May; 50(3):358-62. View Abstract
  135. Expression analysis of macrodactyly identifies pleiotrophin upregulation. PLoS One. 2012; 7(7):e40423. View Abstract
  136. The impact of macromastia on adolescents: a cross-sectional study. Pediatrics. 2012 Aug; 130(2):e339-46. View Abstract
  137. Infantile hemangioma in four siblings. Pediatr Dermatol. 2013 May-Jun; 30(3):e14-5. View Abstract
  138. Current surgical management of bilateral cleft lip in North America. Plast Reconstr Surg. 2012 Jun; 129(6):1347-1355. View Abstract
  139. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations. Plast Reconstr Surg. 2012 Jun; 129(6):919e-924e. View Abstract
  140. Lower-extremity lymphedema and elevated body-mass index. N Engl J Med. 2012 May 31; 366(22):2136-7. View Abstract
  141. Cranial particulate bone graft ossifies calvarial defects by osteogenesis. Plast Reconstr Surg. 2012 May; 129(5):796e-802e. View Abstract
  142. Reply: oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. Plast Reconstr Surg. 2012 May; 129(5):841e. View Abstract
  143. Extradural myelomeningocele reconstruction using local turnover fascial flaps and midline linear skin closure. J Plast Reconstr Aesthet Surg. 2012 Nov; 65(11):1569-72. View Abstract
  144. The effect of obesity on early outcomes in adolescents undergoing reduction mammaplasty. Ann Plast Surg. 2012 Mar; 68(3):257-60. View Abstract
  145. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012 Feb; 68(2):198-201. View Abstract
  146. Primary lymphedema: definition of onset based on developmental age. Plast Reconstr Surg. 2012 Jan; 129(1):221e-222e. View Abstract
  147. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012 Jan; 23(1):149-52. View Abstract
  148. Current concepts of vascular anomalies. J Craniofac Surg. 2012 Jan; 23(1):220-4. View Abstract
  149. Autogenous bone graft: basic science and clinical implications. J Craniofac Surg. 2012 Jan; 23(1):323-7. View Abstract
  150. Critical-size defect ossification: effect of leporid age in a cranioplasty model. J Craniofac Surg. 2011 Nov; 22(6):2341-3. View Abstract
  151. Facial infiltrating lipomatosis: expression of angiogenic and vasculogenic factors. J Craniofac Surg. 2011 Nov; 22(6):2405-8. View Abstract
  152. Intraoperative cooling of iliac bone graft: an experimental evaluation of cell viability. J Oral Maxillofac Surg. 2012 Jul; 70(7):1633-5. View Abstract
  153. Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations. Plast Reconstr Surg. 2011 Oct; 128(4):260e-269e. View Abstract
  154. Vascular anomalies in 5,621 patients: guidelines for referral. J Pediatr Surg. 2011 Sep; 46(9):1784-9. View Abstract
  155. Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. Plast Reconstr Surg. 2011 Sep; 128(3):743-752. View Abstract
  156. Agminated atypical Spitz tumor: large nasal lesion in a child with Down syndrome. J Pediatr Surg. 2011 Jul; 46(7):1435-7. View Abstract
  157. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011 Jun; 127(6):2419-2431. View Abstract
  158. Exchange cranioplasty using autologous calvarial particulate bone graft effectively repairs large cranial defects. Plast Reconstr Surg. 2011 Apr; 127(4):1631-1642. View Abstract
  159. Differential diagnosis of lower extremity enlargement in pediatric patients referred with a diagnosis of lymphedema. Plast Reconstr Surg. 2011 Apr; 127(4):1571-1581. View Abstract
  160. Safety and clinical efficacy of Onyx for embolization of extracranial head and neck vascular anomalies. AJNR Am J Neuroradiol. 2011 Jun-Jul; 32(6):1082-6. View Abstract
  161. Pilomatrixoma imitating infantile hemangioma. J Craniofac Surg. 2011 Mar; 22(2):734-6. View Abstract
  162. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011 Jan; 127(1):347-351. View Abstract
  163. Autologous cranial particulate bone graft: an experimental study of onlay cranioplasty. J Craniofac Surg. 2011 Jan; 22(1):319-23. View Abstract
  164. Preface vascular anomalies. Clin Plast Surg. 2011 Jan; 38(1):ix-x. View Abstract
  165. Vascular anomalies: current overview of the field. Clin Plast Surg. 2011 Jan; 38(1):1-5. View Abstract
  166. Management of hemangiomas and other vascular tumors. Clin Plast Surg. 2011 Jan; 38(1):45-63. View Abstract
  167. Management of lymphatic malformations. Clin Plast Surg. 2011 Jan; 38(1):75-82. View Abstract
  168. Management of venous malformations. Clin Plast Surg. 2011 Jan; 38(1):83-93. View Abstract
  169. Management of arteriovenous malformations. Clin Plast Surg. 2011 Jan; 38(1):95-106. View Abstract
  170. Expression of angiogenic and vasculogenic factors in human lymphedematous tissue. Lymphat Res Biol. 2011; 9(3):143-9. View Abstract
  171. Inlay cranioplasty: an experimental comparison of particulate graft versus bone dust. Plast Reconstr Surg. 2010 Oct; 126(4):1311-1319. View Abstract
  172. Metastatic neuroblastoma mimicking infantile hemangioma. J Pediatr Surg. 2010 Oct; 45(10):2045-9. View Abstract
  173. Subcutaneous epinephrine for vasoconstriction: an evidence-based evaluation. Plast Reconstr Surg. 2010 Sep; 126(3):157e-158e. View Abstract
  174. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg. 2010 May; 64(5):688-90. View Abstract
  175. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma. Pediatr Dermatol. 2010 May-Jun; 27(3):322-3. View Abstract
  176. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010 Apr; 125(4):1185-1194. View Abstract
  177. Infantile myofibroma or lymphatic malformation: differential diagnosis of neonatal cystic cervicofacial lesions. J Craniofac Surg. 2010 Mar; 21(2):422-6. View Abstract
  178. Perioperative corticosteroid reduces hospital stay after fronto-orbital advancement. J Craniofac Surg. 2010 Mar; 21(2):344-8. View Abstract
  179. Autologous cranial particulate bone grafting reduces the frequency of osseous defects after cranial expansion. J Craniofac Surg. 2010 Mar; 21(2):318-22. View Abstract
  180. Nipple adenoma in infancy. J Pediatr Surg. 2009 Nov; 44(11):2219-22. View Abstract
  181. Diffuse lipofibromatosis of the lower extremity masquerading as a vascular anomaly. Ann Plast Surg. 2009 Jun; 62(6):703-6. View Abstract
  182. Adult-onset kaposiform hemangioendothelioma in a posttraumatic site. Ann Plast Surg. 2009 Apr; 62(4):456-8. View Abstract
  183. Zygomaticotemporal suture synostosis causes progressive facial deformity and asymmetry. Plast Reconstr Surg. 2009 Apr; 123(4):146e-147e. View Abstract
  184. Increased prevalence of left-handedness in hemifacial microsomia. J Craniofac Surg. 2009 Mar; 20 Suppl 1:690-4. View Abstract
  185. Sturge-Weber syndrome: soft-tissue and skeletal overgrowth. J Craniofac Surg. 2009 Mar; 20 Suppl 1:617-21. View Abstract
  186. Phenotypically unusual combined craniosynostoses: presentation and management. Plast Reconstr Surg. 2008 Sep; 122(3):853-862. View Abstract
  187. Pediatric cranioplasty using particulate calvarial bone graft. Plast Reconstr Surg. 2008 Aug; 122(2):563-571. View Abstract
  188. Soft tissue sarcomas of the hand: functional reconstruction and outcome analysis. Hand (N Y). 2008 Sep; 3(3):229-36. View Abstract
  189. Corticosteroid treatment for problematic infantile hemangioma: evidence does not support an increased risk for cerebral palsy. Pediatrics. 2008 Jun; 121(6):1251-2. View Abstract
  190. Onlay frontal cranioplasty using wire reinforced methyl methacrylate. J Craniomaxillofac Surg. 2008 Apr; 36(3):138-142. View Abstract
  191. Applying to plastic surgery residency: factors associated with medical student career choice. Plast Reconstr Surg. 2008 Mar; 121(3):1049-1053. View Abstract
  192. A critical role for matrix metalloproteinases in liver regeneration. J Surg Res. 2008 Apr; 145(2):192-8. View Abstract
  193. Risk of vascular anomalies with Down syndrome. Pediatrics. 2008 Jan; 121(1):e135-40. View Abstract
  194. Inhibition of intra-abdominal adhesion formation with the angiogenesis inhibitor sunitinib. J Surg Res. 2008 Sep; 149(1):115-9. View Abstract
  195. Primary grafting with autologous cranial particulate bone prevents osseous defects following fronto-orbital advancement. Plast Reconstr Surg. 2007 Nov; 120(6):1603-1611. View Abstract
  196. Homocystinuria: an unrecognized cause of microvascular failure. Plast Reconstr Surg. 2007 Jul; 120(1):6e-12e. View Abstract
  197. Endothelial progenitor cells contribute to accelerated liver regeneration. J Pediatr Surg. 2007 Jul; 42(7):1190-8. View Abstract
  198. Calvarial defects associated with neurofibromatosis type 1. Report of two cases. J Neurosurg. 2007 Jun; 106(6 Suppl):484-9. View Abstract
  199. Intraosseous "hemangiomas" are malformations and not tumors. Plast Reconstr Surg. 2007 May; 119(6):1949-1950. View Abstract
  200. Flap ischemia after pedicled tissue transfer to a lateral thigh wound: an example of complication assessment using the end result system of E. A. Codman. Plast Reconstr Surg. 2007 Apr 15; 119(5):1599-1603. View Abstract
  201. Ernest Amory Codman, M.D. (1869 to 1940): the influence of the End Result Idea on plastic and reconstructive surgery. Plast Reconstr Surg. 2007 Apr 15; 119(5):1606-1609. View Abstract
  202. Schimmelpenning syndrome: an association with vascular anomalies. Cleft Palate Craniofac J. 2007 Mar; 44(2):208-15. View Abstract
  203. Zygomaticotemporal synostosis: a rare cause of progressive facial asymmetry. Cleft Palate Craniofac J. 2007 Jan; 44(1):106-11. View Abstract
  204. Treatment of lower extremity lymphedema with suction-assisted lipectomy. Plast Reconstr Surg. 2006 Oct; 118(5):118e-121e. View Abstract
  205. Prevention of temporal depression that follows fronto-orbital advancement for craniosynostosis. J Craniofac Surg. 2006 Sep; 17(5):980-5. View Abstract
  206. Images in clinical medicine. Skin redundancy after massive weight loss. N Engl J Med. 2006 Aug 24; 355(8):830. View Abstract
  207. Microdeformational wound therapy: effects on angiogenesis and matrix metalloproteinases in chronic wounds of 3 debilitated patients. Ann Plast Surg. 2006 Apr; 56(4):418-22. View Abstract
  208. Determining the need for simulated training of invasive procedures. Adv Health Sci Educ Theory Pract. 2006 Feb; 11(1):41-9. View Abstract
  209. Blood pressure monitoring and venipuncture in the lymphedematous extremity. Plast Reconstr Surg. 2005 Dec; 116(7):2058-9. View Abstract
  210. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg. 2005 Sep; 40(9):1446-53. View Abstract
  211. Management of parotid hemangioma. Plast Reconstr Surg. 2005 Aug; 116(2):676-7. View Abstract
  212. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg. 2005 Jul; 242(1):140-6. View Abstract
  213. Frontonasal osteotomy to facilitate removal of an intracranial nasal dermoid. J Craniofac Surg. 2005 Jul; 16(4):731-6. View Abstract
  214. Pneumonectomy in the mouse: technique and perioperative management. J Invest Surg. 2005 Jul-Aug; 18(4):201-5. View Abstract
  215. Management of epinephrine injection injury to the digit. Plast Reconstr Surg. 2005 May; 115(6):1800-1. View Abstract
  216. Schwannoma of the median nerve: Iatrogenic injury after axillary lymph node biopsy. Surgery. 2005 Mar; 137(3):378-9. View Abstract
  217. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005 Jan; 115(1):22-30. View Abstract
  218. Urinary matrix metalloproteinases and their endogenous inhibitors predict hepatic regeneration after murine partial hepatectomy. Transplantation. 2004 Oct 27; 78(8):1139-44. View Abstract
  219. Wilms tumor screening is unnecessary in Klippel-Trenaunay syndrome. Pediatrics. 2004 Apr; 113(4):e326-9. View Abstract
  220. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med. 2004 Mar; 10(3):255-61. View Abstract
  221. Management of parotid hemangioma in 100 children. Plast Reconstr Surg. 2004 Jan; 113(1):53-60. View Abstract
  222. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg. 2003 Apr; 237(4):530-5. View Abstract
  223. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg. 2003 Mar-Apr; 16(2):99-102. View Abstract
  224. Professor Edmund Rose: his position in surgery. Plast Reconstr Surg. 2003 Jan; 111(1):383-6. View Abstract
  225. Hepatic exstrophy complicating Poland's anomaly. J Pediatr Surg. 2002 Aug; 37(8):1203-4. View Abstract
  226. A resident's guide to personal finance. Curr Surg. 2002 Jul-Aug; 59(4):423-5. View Abstract
  227. Phosphatidylinositol 4,5-bisphosphate modifies tubulin participation in phospholipase Cbeta1 signaling. J Neurosci. 2002 Mar 01; 22(5):1668-78. View Abstract
  228. Laparoscopic splenectomy for massive splenomegaly using a Lahey bag. Am J Surg. 2001 Jun; 181(6):543-6. View Abstract
  229. Ignacio Barraquer (1884-1965) and the Barraquer family of ophthalmologists. Can J Ophthalmol. 2001 Feb; 36(1):5-6. View Abstract
  230. Lluis Barraquer-Roviralta (1855-1928): Spanish neurologist described progressive lipodystrophy. Plast Reconstr Surg. 2001 Jan; 107(1):158-62. View Abstract
  231. Laparoscopically assisted ileocolectomy for Crohn's disease through a pfannenstiel incision. Am J Surg. 2000 Sep; 180(3):238-40. View Abstract
  232. Is sestamibi-guided parathyroidectomy really cost-effective? Surgery. 1999 Dec; 126(6):1036-40; discussion 1040-1. View Abstract
  233. Conditional differentiation of heart- and smooth muscle-derived cells transformed by a temperature-sensitive mutant of SV40 T antigen. J Cell Sci. 1996 Feb; 109 ( Pt 2):397-407. View Abstract
  234. Sequential Tc 99m mercaptoacetyl-triglycine (MAG3) renography as an evaluator of early renal transplant function. Clin Transplant. 1993 Jun; 7(3):245-9. View Abstract
  235. School-based health care: an inner-city experience. R I Med. 1993 Apr; 76(4):185-9. View Abstract
  236. Comparison of topical tetracaine, adrenaline, and cocaine anesthesia with lidocaine infiltration for repair of lacerations in children. Ann Emerg Med. 1990 Jan; 19(1):63-7. View Abstract
  237. Measurement of cardiopulmonary function in ventilated neonates with respiratory distress syndrome using rebreathing methodology. Pediatr Res. 1986 Apr; 20(4):316-20. View Abstract

Contact Arin K. Greene